Literature DB >> 526379

A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane.

J P Fee, G W Black, J W Dundee, P D McIlroy, H M Johnston, S B Johnston, I H Black, H G McNeill, D W Neill, J R Doggart, J D Merrett, J R McDonald, D S Bradley, M Haire, S A McMillan.   

Abstract

A prospective study of liver enzymes and other measurements following repeat administrations of halothane or enflurane was carried out in patients undergoing minor urological operations. The patient populations were similar with respect to frequency of factors which might influence liver function, social habits, drug therapy and time intervals between administrations. Sixty-three received two or more administrations of halothane and 66 received two or more administrations of enflurane, both drugs given with nitrous oxide in oxygen. There was a greater frequency of increased enzymatic activity following repeat administrations of halothane than following enflurane and the average alanine aminotransferase and gamma glutamyl transpeptidase concentrations were increased to a greater degree following halothane than enflurane. There was no change in the eosinophil count and no significant postoperative morbidity. Change in alanine aminotransferase, lactate dehydrogenase and gamma glutamyl transpeptidase occured more frequently in obese patients receiving halothane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526379     DOI: 10.1093/bja/51.12.1133

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

1.  Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane.

Authors:  Y Sakaguchi; S Inaba; Y Umeki; S Takahashi; J Yoshitake; Y Hayashi; K Akazawa; Y Nose
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

Review 2.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 3.  Halothane anaesthesia and liver damage.

Authors:  J Neuberger; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

4.  Anesthesia in 1984: how safe is it?

Authors:  J M Davies; L Strunin
Journal:  Can Med Assoc J       Date:  1984-09-01       Impact factor: 8.262

5.  The liver and halothane--again.

Authors: 
Journal:  Br Med J       Date:  1980-05-17

6.  Comparison of postoperative liver dysfunction following halothane and sevoflurane anesthesia in women undergoing mastectomy for cancer.

Authors:  Saburo Tsujimoto; Hiroko Kato; Yukiko Minamoto; Hideaki Miki; Rie Kitamura
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

Review 7.  Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines.

Authors:  J M Neuberger
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 8.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 9.  Clinical pharmacokinetics of the inhalational anaesthetics.

Authors:  O Dale; B R Brown
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

10.  Halothane hepatitis in an animal model: time course of hepatic damage.

Authors:  K M Knights; G K Gourlay; P D Hall; J F Adams; M J Cousins
Journal:  Br J Exp Pathol       Date:  1987-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.